Ovid Therapeutics Inc (OVID)

Nov 17, 2025

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Nov 17, 2025

Nov 17, 2025

OVID: Leerink Partners Initiates Coverage with 'Outperform' Rati - GuruFocus

Nov 17, 2025

Nov 17, 2025

Leerink Partners Initiates Ovid Therapeutics at Outperform With $5 Price Target - MarketScreener

Nov 17, 2025

Nov 17, 2025

Ovid Therapeutics (OVID) Receives Positive Outlook from Analyst - GuruFocus

Nov 17, 2025

Nov 17, 2025

Historical volatility pattern of Ovid Therapeutics Inc. visualizedEarnings Growth Summary & Accurate Entry/Exit Alerts - newser.com

Nov 17, 2025

Nov 17, 2025

How Ovid Therapeutics Inc. (1OT) stock correlates with oil marketsMarket Activity Report & Consistent Profit Trading Strategies - newser.com

Nov 17, 2025

Nov 16, 2025

What consensus target says about Ovid Therapeutics Inc. (1OT) stock2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com

Nov 16, 2025

Nov 16, 2025

Will Ovid Therapeutics Inc. (1OT) stock see valuation expansionJuly 2025 Trends & Momentum Based Trading Ideas - newser.com

Nov 16, 2025

Nov 16, 2025

Combining machine learning predictions for Ovid Therapeutics Inc.Trend Reversal & Trade Opportunity Analysis - newser.com

Nov 16, 2025

Nov 16, 2025

Visual trend scoring systems applied to Ovid Therapeutics Inc.July 2025 Decliners & Verified Short-Term Plans - newser.com

Nov 16, 2025

Nov 16, 2025

Published on: 2025-11-16 07:02:40 - newser.com

Nov 16, 2025

Nov 16, 2025

Regression analysis insights on Ovid Therapeutics Inc. performance2025 Winners & Losers & Risk Managed Investment Strategies - newser.com

Nov 16, 2025

Nov 16, 2025

Published on: 2025-11-16 05:07:57 - newser.com

Nov 16, 2025

Nov 16, 2025

Can trapped investors hope for a rebound in Ovid Therapeutics Inc.Portfolio Risk Report & Free Technical Pattern Based Buy Signals - newser.com

Nov 16, 2025

Nov 14, 2025

Published on: 2025-11-14 21:11:45 - newser.com

Nov 14, 2025

Nov 14, 2025

Is Ovid Therapeutics Inc. (1OT) stock protected from inflationWeekly Profit Summary & Real-Time Buy Signal Notifications - newser.com

Nov 14, 2025

Nov 14, 2025

Is Ovid Therapeutics Inc. stock oversold or undervaluedPortfolio Update Report & Community Driven Trade Alerts - Fundação Cultural do Pará

Nov 14, 2025

Nov 12, 2025

Meg Alexander to become Ovid Therapeutics CEO as pipeline advances By Investing.com - Investing.com Nigeria

Nov 12, 2025

Nov 12, 2025

What MACD trends signal for Ovid Therapeutics Inc. (1OT) stockQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com

Nov 12, 2025

Nov 12, 2025

Ovid Therapeutics Reports Q3 2025 Financial Results - TipRanks

Nov 12, 2025

Nov 12, 2025

Ovid Therapeutics Draws Strong Buy Ratings After Q3 Earnings Update - Finimize

Nov 12, 2025

Nov 12, 2025

Ovid Therapeutics earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada

Nov 12, 2025

Nov 12, 2025

Ovid Therapeutics (OVID) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 12, 2025

Nov 12, 2025

Ovid Therapeutics Names Meg Alexander CEO - MarketScreener

Nov 12, 2025

Nov 12, 2025

Meg Alexander to become Ovid Therapeutics CEO as pipeline advances - Investing.com India

Nov 12, 2025

Nov 12, 2025

Ovid (OVID) Reports Q3 Revenue Below Expectations - GuruFocus

Nov 12, 2025

Nov 12, 2025

Ovid Therapeutics Q3 revenue slightly beats expectations - MarketScreener

Nov 12, 2025

Nov 12, 2025

Ovid Therapeutics Announces Meg Alexander as New CEO and Provides Pipeline and Financial Updates - Quiver Quantitative

Nov 12, 2025

Nov 12, 2025

Ovid Therapeutics Inc. SEC 10-Q Report - TradingView

Nov 12, 2025

Nov 12, 2025

[10-Q] Ovid Therapeutics Inc. Quarterly Earnings Report | OVID SEC FilingForm 10-Q - Stock Titan

Nov 12, 2025

Nov 12, 2025

Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results - The Manila Times

Nov 12, 2025

Nov 12, 2025

[8-K] Ovid Therapeutics Inc. Reports Material Event | OVID SEC FilingForm 8-K - Stock Titan

Nov 12, 2025

Nov 12, 2025

Ovid Therapeutics (NASDAQ: OVID) details up to $175M private placement, runway into 2H 2028 - Stock Titan

Nov 12, 2025

Nov 12, 2025

Metagenomi, Ovid CEOs step aside; Cogent soars on ‘unprecedented’ stomach cancer data - Yahoo Finance

Nov 12, 2025